B
Belinda Fazekas
Researcher at Flinders University
Publications - 44
Citations - 2332
Belinda Fazekas is an academic researcher from Flinders University. The author has contributed to research in topics: Palliative care & Placebo. The author has an hindex of 20, co-authored 38 publications receiving 2079 citations. Previous affiliations of Belinda Fazekas include Repatriation General Hospital.
Papers
More filters
Journal ArticleDOI
Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea
TL;DR: Sustained release, oral morphine at low dosage provides significant symptomatic improvement in refractory dyspnoea in the community setting.
Journal ArticleDOI
The Australia-modified Karnofsky Performance Status (AKPS) scale: a revised scale for contemporary palliative care clinical practice [ISRCTN81117481]
Amy P. Abernethy,Amy P. Abernethy,Amy P. Abernethy,Tania Shelby-James,Belinda Fazekas,David Woods,David C. Currow,David C. Currow +7 more
TL;DR: The Australia-modified KPS is a useful modification of the Karnofsky Performance Status that is more appropriate for clinical settings that include multiple venues of care such as palliative care.
Journal ArticleDOI
Efficacy of oral risperidone, haloperidol, or placebo for symptoms of delirium among patients in palliative care: a randomized clinical trial
Meera Agar,Peter G. Lawlor,Stephen Quinn,Brian Draper,Gideon A. Caplan,Debra Rowett,Christine Sanderson,Janet Hardy,Brian Le,Simon Eckermann,Nicola McCaffrey,Linda Devilee,Belinda Fazekas,Mark A. Hill,David C. Currow +14 more
TL;DR: In patients receiving palliative care, individualized management ofdelirium precipitants and supportive strategies result in lower scores and shorter duration of target distressing delirium symptoms than when risperidone or haloperidol are added.
Journal ArticleDOI
Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Toxicity of Subcutaneous Ketamine in the Management of Cancer Pain
Janet Hardy,Stephen Quinn,Belinda Fazekas,John L. Plummer,Simon Eckermann,Meera Agar,Odette Spruyt,Debra Rowett,David C. Currow +8 more
TL;DR: Ketamine does not have net clinical benefit when used as an adjunct to opioids and standard coanalgesics in cancer pain and is considered of net benefit if it provided clinically relevant improvement in pain with limited breakthrough analgesia and acceptable toxicity.
Journal ArticleDOI
Specialized palliative care services are associated with improved short- and long-term caregiver outcomes.
Amy P. Abernethy,Amy P. Abernethy,Amy P. Abernethy,David C. Currow,David C. Currow,Belinda Fazekas,Mary A. Luszcz,Jane L. Wheeler,Maragatha Kuchibhatla +8 more
TL;DR: At a population level, SPCS were associated with meaningful improvements in short-term (“unmet needs”) and long-term caregiver-defined outcomes.